Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial

MLA

Lenze, Eric J., et al. “Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results from an 8-Week Randomized, Placebo-Controlled Trial.” American Journal of Psychiatry, vol. 162, no. 1, Jan. 2005, p. 146. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.127543960&authtype=sso&custid=ns315887.

APA

Lenze, E. J., Mulsant, B. H., Shear, M. K., Dew, M. A., Miller, M. D., Pollock, B. G., Houck, P., Tracey, B., & Reynolds, C. F., III. (2005, January 1). Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. American Journal of Psychiatry, 162(1), 146.

Chicago

Lenze, Eric J., Benoit H. Mulsant, M. Katherine Shear, Mary Amanda Dew, Mark D. Miller, Bruce G. Pollock, Patricia Houck, Barbara Tracey, and Charles F. Reynolds III. 2005. “Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results from an 8-Week Randomized, Placebo-Controlled Trial.” American Journal of Psychiatry, January 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.127543960&authtype=sso&custid=ns315887.